Home pageCRL • NYSE
add
Charles River Laboratories International, Inc.
Chiusura precedente
163,69Â $
Intervallo giornaliero
159,65Â $ - 163,00Â $
Intervallo annuale
159,65Â $ - 275,00Â $
Cap di mercato
8,29Â Mld USD
Volume medio
802.664,00
Rapporto P/E
20,24
Dividendo/Prezzo
-
Borsa valori principale
NYSE
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
(USD) | set 2024info | Variazione Y/Y |
---|---|---|
Entrate | 1,01Â Mld | -1,64% |
Spese di gestione | 219,42Â Mln | 5,38% |
Utile netto | 69,66Â Mln | -20,29% |
Margine di profitto netto | 6,90 | -18,92% |
Utili per azione | 2,59 | -4,78% |
EBITDA | 236,55Â Mln | -4,13% |
Aliquota fiscale effettiva | 22,96% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(USD) | set 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 210,17Â Mln | 33,72% |
Totale attivo | 8,00Â Mld | 5,22% |
Totale passivo | 4,18Â Mld | -1,88% |
Patrimonio netto totale | 3,83 Mld | — |
Azioni in circolazione | 51,14 Mln | — |
Prezzo/valore contabile | 2,21 | — |
Redditività dell'attivo | 4,65% | — |
Rendimento sul capitale | 5,62% | — |
Flusso di cassa
Flusso di cassa netto
(USD) | set 2024info | Variazione Y/Y |
---|---|---|
Utile netto | 69,66Â Mln | -20,29% |
Liquidità di esercizio | 251,79 Mln | 22,56% |
Contanti da investimenti | -21,32Â Mln | 73,20% |
Contanti da finanziamenti | -207,54Â Mln | -27,43% |
Flusso di cassa netto | 30,64Â Mln | 170,98% |
Flusso di cassa libero | 223,49Â Mln | 120,91% |
Informazioni
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Fondazione
1947
Sito web
Dipendenti
21.100